Medica Group (MGP) Stock Rating Reaffirmed by Berenberg Bank

Medica Group (LON:MGP)‘s stock had its “buy” rating reaffirmed by Berenberg Bank in a research report issued to clients and investors on Friday. They currently have a GBX 230 ($2.93) price objective on the stock. Berenberg Bank’s price objective suggests a potential upside of 56.46% from the company’s previous close.

Separately, Numis Securities raised Medica Group to a “buy” rating and set a GBX 150 ($1.91) price objective on the stock in a research note on Friday, May 4th.

Shares of MGP traded up GBX 1 ($0.01) during midday trading on Friday, reaching GBX 147 ($1.88). The stock had a trading volume of 50,693 shares, compared to its average volume of 235,604. Medica Group has a 52 week low of GBX 135 ($1.72) and a 52 week high of GBX 242 ($3.09).

About Medica Group

Medica Group Plc provides teleradiology reporting services to NHS trusts and other customers in the United Kingdom. It offers same day routine teleradiology, radiographer plain film, NightHawk emergency CT and MR reporting, Dayhawk fast daytime, and CT colonography reporting services. The company also provides audit services, such as cause for concern audit, departmental quality assurance, and ongoing CT, MR, plain film, and ultrasound audit services; and specialist services.

Further Reading: Outstanding Shares and The Effect on Share Price

Receive News & Ratings for Medica Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medica Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply